Steven P. Gelone - 31 Aug 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRVF)

Role
President and COO, Director
Signature
/s/ Robert Crotty, by power of attorney
Issuer symbol
NBRVF
Transactions as of
31 Aug 2021
Transactions value $
-$67
Form type
4
Filing time
02 Sep 2021, 16:09:28
Previous filing
10 Aug 2021
Next filing
08 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRVF Ordinary Shares Tax liability -$67 -63 -0.02% $1.06 367K 31 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.